A carregar...
Optimizing the use of biological therapy in patients with inflammatory bowel disease
Biological therapy revolutionized the treatment of inflammatory bowel disease (IBD) during the last decade. These monoclonal antibodies, which target tumor necrosis factor (TNF), integrins or IL12/23, have been approved—or are in development for—both Crohn’s disease (CD) and ulcerative colitis (UC)....
Na minha lista:
| Publicado no: | Gastroenterol Rep (Oxf) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324872/ https://ncbi.nlm.nih.gov/pubmed/25567472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/gou087 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|